EGFR™ inhibitor, demonstrates preliminary anti-tumor activity across a variety of advanced EGFR-mutant non-small cell lung cancers with complex and difficult-to-treat resistance mutations ...

It’s been a tough month for Texas workers. Thousands of employees have been notified of facility closures, contract ends or ...